Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection

NCT07552584 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT07552584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07552584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection
Lead sponsor
Vejle Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 26, 2026
Completion date
April 30, 2034
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (diagnosis)